Therefore, extraction of Aβ42, T-tau or P-tau181 in neurogenic exosomes can more specifically reflect the pathological changes of the central nervous system, suggesting that neurogenic exosome proteins in peripheral blood may be used for clinical diagnosis of AD. The gene discussed is MAPT; the disease is Alzheimer disease.